Clinical trial
Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation
NCT00154440 · Technische Universität Dresden, Other · Unknown status
Key facts
| NCT number | NCT00154440 |
|---|---|
| Title | Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation |
| Official title | Treatment of Low-Grade Gastric Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type Stages IE & II1E (HELYX-Study) |
| Lead sponsor | Technische Universität Dresden, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin |
| Intervention type | Drug, Procedure |
| Interventions | proton pump inhibitor, clarithromycin, amoxicillin, metronidazole, radiation therapy |
| Enrollment | 200 |
| Start date | Nov 1, 2001 |
| Completion | Oct 1, 2013 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 26, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: